- [Resource Hub](/)
- [Resource](/?resource-type=poster#library)
- Multiplex Immunofluorescence Staining, Whole Slide Imaging, and Spatial Phenotyping of T cell Exhaustion, Regulatory T cells, and Myeloid Derived Suppressor Cells in Tumor FFPE Samples

# Multiplex Immunofluorescence Staining, Whole Slide Imaging, and Spatial Phenotyping of T cell Exhaustion, Regulatory T cells, and Myeloid Derived Suppressor Cells in Tumor FFPE Samples

Profiling exhausted T cells, regulatory T cells, and myeloid-derived suppressor cells in the tumor microenvironment demands many markers, spatial context, and fast turnaround at once; this SITC 2019 poster combines three UltiMapper I/O immunofluorescence panels, whole-slide scanning on the RareCyte CyteFinder II HT, and HALO image analysis to phenotype these populations across lung, colorectal, and breast tumor FFPE samples with same-day sample-to-results.

Presented by Indica Labs / RareCyte / Ultivue.

Read or download to see:

- Three UltiMapper I/O multiplex immunofluorescence panels profiled the tumor immune microenvironment across lung, colorectal, and breast FFPE tissue. Each panel was imaged in 5 channels — a DAPI channel plus four markers — with a PD-1 panel for immune-cell exhaustion, a T-reg panel for regulatory and cytotoxic T cells, and an MDSC panel for myeloid-derived suppressor cells.

- The automated workflow returned same-day sample-to-results, from staining through analysis. Staining on a Leica BOND RX autostainer completed in 5.5 hours, whole-slide scanning ran about 15 minutes per slide on the RareCyte CyteFinder II HT, and HALO image analysis finished in 10 minutes.

- Serial sections stained with the three panels were co-registered in HALO onto one coordinate system for spatial phenotyping. Cytotoxic T-cell infiltration was quantified 200 µm inside and 200 µm outside the tumor margin, and T-helper-cell density was measured within a 25 µm radius, resolving immune phenotypes by their position relative to the tumor margin and stroma.

[Download poster](https://cdn.sanity.io/files/s3p6uqps/production/46ccee5156e1beb1951d23261d9a821d2af165c1.pdf)

Your browser doesn’t support embedded PDFs.
[Download the poster](https://cdn.sanity.io/files/s3p6uqps/production/46ccee5156e1beb1951d23261d9a821d2af165c1.pdf) to view it.

[Back to all resources](/#library)
## Related resources
[Article](https://www.selectscience.net/product-news/measuring-versus-reading-transforming-the-field-of-quantitative-pathology?artid=58733) CyteFinder SelectScience
### Measuring versus reading – transforming the field of quantitative pathology
[Read Article](https://www.selectscience.net/product-news/measuring-versus-reading-transforming-the-field-of-quantitative-pathology?artid=58733) [Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyyz/455452/220141/TS20_103.pdf) CyteFinder
### CyteFinder II HT
[View Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyyz/455452/220141/TS20_103.pdf) [Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyz2/455452/220143/TS20_104.pdf) CyteFinder
### CyteFinder II
[View Spec Sheet](https://go.pardot.com/l/455452/2019-11-18/7mzyz2/455452/220143/TS20_104.pdf) [Publication](https://doi.org/10.1200/JCO.2026.44.16_suppl.5041) CyteFinder Journal of Clinical Oncology 2026
### Clinical validation of circulating tumor cell synaptophysin and androgen receptor expression in metastatic prostate cancer phenotypes.
[View Publication](https://doi.org/10.1200/JCO.2026.44.16_suppl.5041) [Video](https://www.youtube.com/watch?v=_oGC1KRVN2U) CyteFinder 2026
### Dr. Pashtoon Kasi on the impact of circulating tumor cells on clinical research
[Watch Video](https://www.youtube.com/watch?v=_oGC1KRVN2U) [Publication](https://doi.org/10.1038/s41587-026-03099-z) CyteFinder Nature Biotechnology 2026
### mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression
[View Publication](https://doi.org/10.1038/s41587-026-03099-z) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC7618831/) CyteFinder Cancer Immunology Research 2026
### Ex Vivo Immuno-Oncology Platform Reveals Spatial T Cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC7618831/) [Publication](https://doi.org/10.1097/pai.0000000000001311) CyteFinder Applied Immunohistochemistry & Molecular Morphology 2026
### Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
[View Publication](https://doi.org/10.1097/pai.0000000000001311) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12881594/) CyteFinder Nature Communications 2026
### Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12881594/) [Publication](https://doi.org/10.1016/j.ejso.2025.111357) CyteFinder European Journal of Surgical Oncology 2026
### Circulating tumor cells predict relapse in head and neck mucosal squamous cell carcinoma
[View Publication](https://doi.org/10.1016/j.ejso.2025.111357) [Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12805936/) CyteFinder Cancer Research Communications 2026
### Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer
[View Publication](https://pmc.ncbi.nlm.nih.gov/articles/PMC12805936/) [Publication](https://doi.org/10.1158/1078-0432.CCR-25-0244) CyteFinder Clinical Cancer Research 2025
### Pre-clinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-wildtype Glioblastoma
[View Publication](https://doi.org/10.1158/1078-0432.CCR-25-0244)